Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: HALOPERIDOL — Supplemental Application (AiPing Pharmaceutical, Inc)

View source ↗

Summary

FDA approved AiPing Pharmaceutical's supplemental application for haloperidol, a generic antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

SUPPL AP for HALOPERIDOL (HALOPERIDOL)